Portfolio (Quarterly)
Guide ↗
STEMPOINT CAPITAL LP
· CIK 0001952142| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SRRK | SCHOLAR ROCK HLDG CORP | Healthcare | 1,035,496.0 | $50.9M | 9.74% | NEW | — | $49.16 | -1.8% |
| 2 | ABVX | ABIVAX SA | Healthcare | 313,791.0 | $34.9M | 6.69% | NEW | — | $111.35 | +4.8% |
| 3 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 1,215,743.0 | $28.4M | 5.44% | NEW | — | $23.36 | -13.7% |
| 4 | RVMD | REVOLUTION MEDICINES INC | Healthcare | 281,632.0 | $27.4M | 5.24% | NEW | — | $97.25 | +57.8% |
| 5 | IMVT | IMMUNOVANT INC | Healthcare | 746,494.0 | $18.5M | 3.55% | NEW | — | $24.84 | +30.5% |
| 6 | — | PRAXIS PRECISION MEDICINES I | — | 56,267.0 | $18.1M | 3.47% | NEW | — | $322.19 | — |
| 7 | MBX | MBX BIOSCIENCES INC | Healthcare | 499,469.0 | $14.9M | 2.85% | NEW | — | $29.85 | +4.9% |
| 8 | MLYS | MINERALYS THERAPEUTICS INC | Healthcare | 533,378.0 | $14.4M | 2.77% | NEW | — | $27.09 | -0.2% |
| 9 | ELVN | ENLIVEN THERAPEUTICS INC | Healthcare | 363,438.0 | $14.2M | 2.73% | NEW | — | $39.20 | +4.1% |
| 10 | CGON | CG ONCOLOGY INC | Healthcare | 205,622.0 | $13.9M | 2.66% | NEW | — | $67.68 | -5.0% |
| 11 | — | BIOHAVEN LTD | — | 1,594,491.0 | $13.5M | 2.58% | NEW | — | $8.46 | — |
| 12 | — | SURROZEN INC | — | 525,639.0 | $13.5M | 2.58% | NEW | — | $25.61 | — |
| 13 | ROIV | ROIVANT SCIENCES LTD | Healthcare | 385,800.0 | $10.7M | 2.05% | NEW | — | $27.70 | +11.1% |
| 14 | EYPT | EYEPOINT INC | Healthcare | 810,764.0 | $10.5M | 2.00% | NEW | — | $12.89 | -4.4% |
| 15 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 413,792.0 | $9.7M | 1.87% | NEW | — | $23.56 | -15.3% |
| 16 | GPCR | STRUCTURE THERAPEUTICS INC | Healthcare | 200,267.0 | $9.7M | 1.85% | NEW | — | $48.20 | -24.6% |
| 17 | AMLX | AMYLYX PHARMACEUTICALS INC | Healthcare | 669,685.0 | $9.3M | 1.78% | NEW | — | $13.90 | -6.2% |
| 18 | DYN | DYNE THERAPEUTICS INC | Healthcare | 506,075.0 | $9.2M | 1.76% | NEW | — | $18.13 | -7.7% |
| 19 | EWTX | EDGEWISE THERAPEUTICS INC | Healthcare | 290,864.0 | $9.2M | 1.75% | NEW | — | $31.50 | +1.9% |
| 20 | CYTK | CYTOKINETICS INC | Healthcare | 129,577.0 | $8.5M | 1.64% | NEW | — | $65.91 | +17.0% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
99.3%
Financial Services
0.7%